Pin35 - Cost-Effectiveness of Bezlotoxumab for the Prevention of Recurrence of Clostridium Difficile Infection in Portugal

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prevention and Treatment of Clostridium Difficile Infection

Geriatric Care
2017English

Real-World Efficacy of Bezlotoxumab for Prevention of Recurrent Clostridium Difficile Infection: A Retrospective Study of 46 Patients in Five University Hospitals in Finland

European Journal of Clinical Microbiology and Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

The Difficile in Clostridium Difficile Infection

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2018English

Cost-Effectiveness Analysis Evaluating Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium Difficile Infection

Frontiers in Microbiology
Microbiology
2018English

Clostridium Difficile Infection

Nature Reviews Disease Primers
Medicine
2016English

Clostridium Difficile Infection

Nature Reviews Disease Primers
Medicine
2016English

Epidemiology of Clostridium Difficile Infection

Journal of Pharmacy Practice
PharmacologyPharmacy
2013English

Clostridium Difficile Infection

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy